What is a stock summary page? Click here for an overview.
Business Description
Aravive Inc
NAICS : 325412
SIC : 2834
ISIN : US92529L1026
Compare
Compare
Traded in other countries / regions
ARAV.USAVE11.Germany Index Membership
Russell 2000 IPO Date
2014-03-21Description
Aravive Inc is a clinical-stage biopharmaceutical company. It focuses on developing treatments designed to halt the progression of life-threatening diseases, including cancer and fibrosis. The company pipeline product Batiraxcept (formerly AVB-500) which is an ultra-high affinity decoy protein that binds to GAS6 and thereby prevents AXL signaling to inhibit metastasis and tumor growth and restore sensitivity to anti-cancer agents. Batiraxcept is currently being evaluated in multiple clinical trials.
Financial Strength
| Name | Current | Vs Industry | Vs History |
|---|
Growth Rank
| Name | Current | Vs Industry | Vs History |
|---|
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 6-1 Month Momentum % | -51.29 | |||||
| 12-1 Month Momentum % | -94.21 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| FCF Margin % | -849.92 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-Forward-EBIT | -0.07 | |||||
| EV-to-Forward-EBITDA | -0.07 | |||||
| EV-to-Forward-Revenue | 1.3 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ARAV
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Aravive Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 6.995 | ||
| EPS (TTM) ($) | -0.96 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | -1.03 | ||
| 3-Year Sortino Ratio | -1.14 | ||
| Volatility % | 117.57 | ||
| 14-Day RSI | - | ||
| 14-Day ATR ($) | 0.003414 | ||
| 20-Day SMA ($) | - | ||
| 12-1 Month Momentum % | -94.21 | ||
| 52-Week Range ($) | 0.04 - 2.46 | ||
| Shares Outstanding (Mil) | 73.56 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 0 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Aravive Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Aravive Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Aravive Inc Frequently Asked Questions
What is Aravive Inc(ARAV)'s stock price today?
The current price of ARAV is $0.04. The 52 week high of ARAV is $2.46 and 52 week low is $0.04.
When is next earnings date of Aravive Inc(ARAV)?
The next earnings date of Aravive Inc(ARAV) is .
Does Aravive Inc(ARAV) pay dividends? If so, how much?
Aravive Inc(ARAV) does not pay dividend.
Guru Commentaries on NAS:ARAV
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers